FDA Inspection 1159971 — Myovant Sciences, Inc.
The FDA completed an inspection of Myovant Sciences, Inc. on Dec 17, 2021 in Brisbane, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 17, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brisbane, CA (United States)
Additional details
Sponsor, Contract Research Organization